Glycolysis
Glycolysis: The Investment-and-Payoff Pathway
Why does a cell spend ATP to make ATP? Because the first three steps of glycolysis are a deliberate investment. This lesson tracks one glucose through all ten steps — two ATP spent up front, four earned at the end, two NADH banked — and shows why the three irreversible steps are exactly where the cell installs its throttle.
When Usain Bolt runs 100 meters in under ten seconds, his leg muscles burn glucose faster than his blood can deliver oxygen. So his cells do the next-best thing: they break glucose down without it. That pathway is glycolysis, and it is running in nearly every cell on Earth right now — in your neurons, in brewer’s yeast, in bacteria that have never met oxygen.
The puzzle that makes glycolysis worth studying is hiding in plain sight. The cell’s whole point is to make ATP. Yet the first thing glycolysis does is spend it. Two ATP go in before a single one comes out. Why would a starving cell pay a toll to enter a pathway whose job is to earn?
The idea: invest first, then collect
Think of glycolysis as a small business that has to spend money to make money. The ten steps fall into two phases.
The investment phase (steps 1–3) primes the glucose molecule. Hexokinase spends one ATP to phosphorylate glucose, and phosphofructokinase-1 spends a second. By the end of step 5 the ledger reads −2 ATP, nothing earned. The cell has put down a deposit and seen no return.
Then the molecule is cut in half. Aldolase splits the six-carbon sugar into two three-carbon fragments, and triose phosphate isomerase converts one of them into a second copy of the other — so two identical three-carbon molecules now head down the rest of the path. From here, everything happens twice. From step 6 onward every yield counts double — the doubling students most often forget when they tally the ledger.
The payoff phase (steps 6–10) collects. One oxidation step (GAPDH) banks the energy as NADH and primes a high-energy phosphate. Two later steps — phosphoglycerate kinase and pyruvate kinase — hand that phosphate directly to ADP, making ATP by what’s called substrate-level phosphorylation: no mitochondrion, no oxygen, no membrane gradient, just one enzyme moving a phosphate from substrate to ADP. Each of those two steps fires twice, so the payoff phase earns +4 ATP and +2 NADH.
Subtract the deposit from the return and the books balance:
Net per glucose: +2 ATP, +2 NADH.
It is a thin margin. Two ATP is a rounding error next to the roughly thirty that full respiration extracts later. But glycolysis is fast, it needs no oxygen, and for some cells it is the only option. A red blood cell has no mitochondria at all; glycolysis is its entire energy economy. Walk through all ten steps below and watch the ledger build.
Investment phase steps 1–3 · spend 2 ATP
Spends one ATP to phosphorylate glucose. Induced fit closes the enzyme around the sugar, excluding water so ATP isn’t wasted on hydrolysis — and the charged product can no longer cross the membrane, trapping glucose inside the cell.
Regulation. Inhibited by its own product, glucose-6-phosphate.
Aldose → ketose: a quiet repositioning of the carbonyl so the six-carbon sugar can later be split cleanly down the middle.
The committed step. Once fructose-1,6-bisphosphate forms, the molecule is locked into glycolysis. The second and last ATP is spent here.
Regulation. Inhibited by ATP and citrate; activated by AMP and fructose-2,6-bisphosphate. This is the master throttle of glycolytic flux.
Cleavage steps 4–5 · split into two trioses
Splits the six-carbon sugar into two three-carbon halves — the symmetry break the whole pathway is built around.
Converts DHAP into a second glyceraldehyde-3-phosphate, so both three-carbon halves run the payoff phase. From here, everything counts twice.
Clinical. TPI deficiency: when this enzyme fails, DHAP piles up and forms toxic methylglyoxal. It is the most severe glycolytic enzymopathy — hemolytic anemia plus progressive neurodegeneration.
Payoff phase steps 6–10 · ×2, earn 4 ATP + 2 NADH
The only oxidation step. A thioester on an active-site cysteine couples oxidation to phosphate capture — using inorganic phosphate, not ATP — and banks the energy as NADH.
The first ATP is made here by substrate-level phosphorylation: the high-energy phosphate goes straight from substrate to ADP. The ledger is now back to break-even.
Moves the phosphate from the third carbon to the second, setting up the next step’s dehydration.
A dehydration traps the molecule as an unstable enol, loading phosphoenolpyruvate with the highest phosphoryl-transfer potential in the whole pathway.
Phosphoenolpyruvate hands its phosphate to ADP — the second substrate-level ATP — and the pathway ends at pyruvate.
Regulation. Activated by fructose-1,6-bisphosphate (feedforward); inhibited by ATP and alanine; the liver isoform is switched off by PKA phosphorylation during fasting.
The three locks: where the cell installs its throttle
Most of the ten steps are reversible — they sit near equilibrium and run in whichever direction the cell needs. Three do not. Hexokinase (step 1), PFK-1 (step 3), and pyruvate kinase (step 10) each release a large amount of free energy (ΔG roughly −33, −22, and −17 kJ/mol), which makes them effectively one-way doors.
That irreversibility is not a flaw. It is the whole point. A reaction near equilibrium can’t be controlled — nudge it and it slides right back. A reaction far from equilibrium can be throttled, because the cell can hold the door shut. So the three irreversible steps are exactly the three the cell regulates.
The committed step is PFK-1, and it carries a beautiful paradox. ATP is its substrate — and also its inhibitor. When ATP is high, the cell doesn’t need more, so ATP binds a second site and shuts PFK-1 down. When ATP runs low, its breakdown product AMP rises and switches the enzyme back on. The enzyme isn’t asking “is there glucose?” It’s asking “does this cell need energy right now?” That is feedback control written in protein.
The same enzyme is wired differently in different tissues, which is the deeper lesson. Muscle PFK-1 listens to the muscle’s own energy charge — local, immediate, “I need ATP now.” Liver PFK-1 listens to hormones from the pancreas instead: insulin says store glucose, glucagon says release it. Same protein, opposite job, because the tissue’s purpose differs. Enzyme identity does not determine regulation; context does.
Why pyruvate, not glucose, is the real bottleneck
Here is the part that surprises people. The thing that can stall glycolysis isn’t running out of glucose. It’s running out of NAD+.
Step 6 consumes NAD+ and produces NADH. But the cell holds only a small, fixed pool of NAD+, and it must be recycled or the pathway grinds to a halt within seconds. So pyruvate’s fate is really about regenerating that NAD+. A sprinting muscle does it by handing the electrons to pyruvate itself, making lactate and recovering NAD+ in one step. Yeast does the same thing by making ethanol — which is convenient for brewers but incidental to the yeast, who care only about their NAD+.
- Product
- Acetyl-CoA → CO₂
- NAD⁺ regenerated?
- by the electron-transport chain
With oxygen, pyruvate is fully oxidized and NADH is reoxidized by the electron-transport chain — the high-yield route.
Fermentation makes no extra ATP. Its entire job is to regenerate NAD⁺ so glycolysis (and its 2 ATP per glucose) can keep running when oxygen is scarce.
This is also why lactate gets a bad reputation it doesn’t deserve. It is not a fatigue toxin. It regenerates NAD+ so you can keep running, it travels to the liver to be rebuilt into glucose (the Cori cycle), and it even acts as a signal. The burn in your legs is not the lactate. The lactate is the rescue.
Proving the pathway: isotope tracing and enzyme assays
The net yield was counted, not assumed — by labeling one carbon of glucose with a heavy or radioactive isotope and tracing where it lands. That tracing proved the six-carbon sugar splits into two three-carbon halves and that both halves run the payoff phase. The same trick, scaled up to a PET scanner, reads glucose uptake in a living tumor: cancer cells run glycolysis hard even when oxygen is plentiful, and an ¹⁸F-labeled glucose analog lights them up. To find the throttles, you assay the regulated enzymes directly — add ATP, AMP, or citrate to purified PFK-1 one at a time and watch the velocity climb or fall. That is how the committed step gave up its secrets: the same initial-velocity discipline from enzyme kinetics, turned on one enzyme at a time.
How we measure it
ATP and NADH accounting (the ledger)
The net yield isn't asserted — it's counted. Tally ATP spent (steps 1, 3) against ATP made (steps 7, 10) and NADH made (step 6), doubling everything after the aldolase cleavage. The books balance at +2 ATP and +2 NADH per glucose, and the running ledger is the single most exam-tested skill in the chapter.
Isotopic carbon tracing
Feed cells glucose labeled at a specific carbon — say ¹³C or ¹⁴C on C1 — and follow where that atom lands. Tracing is how the field proved the symmetric six-carbon sugar splits into two three-carbon halves, and why both halves run the payoff phase. The same trick, scaled to a PET scanner, reads a tumor's glucose appetite off an ¹⁸F-labeled analog.
Enzyme assays for the regulated steps
To find a throttle you measure the enzyme's velocity while changing one effector at a time. Adding ATP, citrate, AMP, or fructose-2,6-bisphosphate to purified PFK-1 and watching the rate rise or fall is how the regulators of the committed step were mapped — the same initial-velocity logic from enzyme kinetics, applied one molecule at a time.